Etoposide cas: 33419-42-0

CAS NO: 33419-42-0
Etoposide
Description Review
Description

Etoposide, also known as VP-16, is a chemotherapy drug that has been used to treat various types of cancer. This drug works by preventing cells from dividing, ultimately damaging the DNA inside cancer cells and inhibiting their ability to grow and reproduce. Etoposide is commonly used in combination with other chemotherapy drugs to maximize its efficacy. It can be administered orally or intravenously.

Chemical name:

Etoposide's chemical name is 4'-Demethylepipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside], 4'-demethyl-epipodophyllotoxin, VP-16.

Molecular formula:

The molecular formula of Etoposide is C29H32O13.

Formula Weight:

The formula weight of Etoposide is 588.57 g/mol.

CAS No:

The CAS number of Etoposide is 33419-42-0.

Top Ten Keywords from Google and Synonyms:

  1. Chemotherapy
  2. Cancer treatment
  3. VP-16
  4. Lymphoma
  5. Leukemia
  6. Small cell lung cancer
  7. Topoisomerase II inhibitor
  8. Etopophos
  9. Chemotherapy side effects
  10. Cancer research

Synonyms:

Synonyms of Etoposide include:

• VP-16 • Vepesid • Etopophos • Epipodophyllotoxin

Health benefits of this product:

Etoposide has several potential health benefits, largely related to its usage as a chemotherapy drug. The drug is particularly effective in treating small cell lung cancer, a type of lung cancer that can metastasize quickly. Etoposide has also been shown to be effective in treating other types of cancer, including leukemia and lymphoma.

Potential effects:

Etoposide may have several potential effects, including:

  1. Inhibiting the growth and proliferation of cancer cells
  2. Damaging the DNA inside cancer cells
  3. Halting the process of cell division in cancer cells
  4. Treating small cell lung cancer, leukemia, and lymphoma
  5. Preventing the spread of cancer cells from one part of the body to another (metastasis)

Product mechanism:

Etoposide is a topoisomerase II inhibitor, meaning that it inhibits the activity of the topoisomerase II enzyme, an enzyme critical for DNA replication and repair. By inhibiting this enzyme, Etoposide stops the cancer cells from dividing and ultimately leads to their destruction. This function is critical in the treatment of different types of cancer, including small cell lung cancer, leukemia, and lymphoma.

Safety:

Etoposide has some side effects, most of which are related to its use as a chemotherapy drug. Patients should be monitored closely for side effects, including low white blood cell count and an increased susceptibility to infection. It is not recommended for use during pregnancy or nursing.

Side effects:

The side effects of Etoposide may include:

• Nausea and vomiting • Hair loss • Fatigue and weakness • Mouth sores • Risk of infection • Low white blood cell count • Anemia

Dosing information:

The dosing information for Etoposide should be determined by a healthcare professional. It can be administered orally or intravenously, and the dose and frequency will depend upon the type and stage of cancer being treated.

Conclusion:

Etoposide is a topoisomerase II inhibitor that is effective in treating small cell lung cancer, leukemia, and lymphoma, among other types of cancer. The drug prevents the cancer cells from dividing and ultimately leads to their destruction. While it is a safe drug, patients should be monitored closely for side effects, including low white blood cell count and increased susceptibility to infection. The dosing of Etoposide should only be determined by a healthcare professional.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code